New Technology

Timestrip PLC
18 September 2006



                  TIMESTRIP PLC ('Timestrip' or the 'Company')

                            Technology Breakthrough

              Timestrip develops new label technology for vaccines

Timestrip Plc, which develops and markets unique label technologies, is 
delighted to announce that it has developed a label that is capable of recording
whether temperature sensitive products have been accidentally frozen during 
transport or storage.

The iStripTM is a patent pending label which undergoes an irreversible colour 
change when exposed to freezing temperatures.  Developed in response to demand 
from the pharmaceutical industry, iStripTM is designed to be mass-produced at 
low cost and to be fully integrated into the packaging of products such as 
vaccines, protein based pharmaceuticals, foodstuffs and fertilizer.

Accidental freezing of Diptheria, Tetanus, Pertussis and Hepatitis B vaccines, 
and combination vaccines, can compromise their immunological potency.  Recent 
studies in the UK, USA, Canada, Pakistan, Malaysia, Hungary, Mongolia and other 
countries have found widespread freezing at many levels of the vaccine 
distribution system.  The high incidence of this problem and the resulting 
health risks have made the monitoring and elimination of accidental freezing a 
priority for organizations such as WHO, UNICEF and PATH (Program for Appropriate
Technology in Health).

Paul Freedman, Joint CEO of Timestrip Plc, commented:

'Current indicators cost up to $3.50 per item and can only be used at case or 
pallet level - iStripTM will be marketed at a fraction of this cost, making it a
cost effective option at an individual product level.  We believe that the 
cost-benefit attractions of the technology make it a potential candidate for a
doption as a stipulated feature on vaccines.  We are currently in discussions 
with manufacturers, distributors and global health organizations and are 
targeting initial revenues towards the end of 2007.'

Enquiries:

Paul Freedman/Reuben Isbitsky, Joint CEOs, Timestrip plc           01462 440 700
Shane Dolan, Biddicks                                              020 7448 1000
Fergus Marcroft, Evolution Securities                              020 7071 4300




                      This information is provided by RNS
            The company news service from the London Stock Exchange